MPD: Phenotype measures mapped to MP:0020180, abnormal IgM level

Phenotype measures associated with ontology term
MP:0020180 'abnormal IgM level'

This MP term has been mapped to these MPD phenotype measurements to help users find relevant data. It should be noted that MPD measurements typically have a mixture of high-end, low-end and "normal" readings.

Sort/ Pick	Data set	Procedure / Protocol	Treatment	Phenotype Measure / Variable (click to view)	Panel	No. of Strains	Sex	Age	Sample Size (Avg)	Year
Donahue7:3	Donahue7	immunoglobulin quantification	(none)	immunoglobulin M (plasma IgM) [µg/mL] IgM 41603	B6.A consomic w/par	22	both	9wks	N=8	2012

Donahue8:3	Donahue8	immunoglobulin quantification	(none)	immunoglobulin M (plasma IgM) [µg/mL] IgM 41703	B6.PWD consomic w/par	28	both	9wks	N=8	2011

Eumorphia7:1	Eumorphia7	immunoglobulin quantification	(none)	immunoglobulin M (serum IgM) [µg/mL] IgM 29601	inbred	6	both	9-12wks	N=5	2008

GMC20:2	GMC20	immunoglobulin quantification	(none)	immunoglobulin M (plasma IgM) [µg/mL] IgM 56902 age 16-17wks 20-21wks	inbred w/CC8	8	both		N=6	2018

Graham1:61	Graham1	immunoglobulin quantification	West Nile virus	virus-specific IgM in serum, post infection [ng/mL] WNV_IgM 63361 day 7 day 12 day 21 day 28	CC RIX	5	m	8-10wks	N=3	2015

Noll1:26	Noll1	immunoglobulin quantification	influenza A (H1N1) virus	immunoglobulin M (serum IgM) area under curve (AUC) post-infection [AUC] IgM 112602 post-infection: day 7 day 10 day 15 day 29 day 45	CC RIX	46	f	8-12 wks	N=4	2020